Clinical Trials Browser

Phase 2 × RO5126766 × 1 year × Clear all

NCT04720417 2025-07-15

Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal Melanoma

Phase 2 Terminated

13 enrolled 13 charts

Uveal Melanoma

NCT06495125 2025-04-17

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Phase 2 Recruiting

Adenocarcinoma of Lung, Lung Neoplasms